Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Asunto principal
Tipo de estudio
Intervalo de año de publicación
1.
Dermatol Clin ; 42(3): 471-480, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38796276

RESUMEN

Cytokine blocking therapies have revolutionized the management of psoriasis and atopic dermatitis but can lead to the development of paradoxic psoriasis (PP). Patients treated with biologics should be closely monitored for the development of PP and other paradoxical eruptions (including inflammatory joint disease, inflammatory bowel disease, eczematous eruptions, lupus like eruptions, sarcoidal eruptions, and others) and occasionally the development of cutaneous T-cell lymphoma. Further understanding the immunologic mechanism of these processes will ultimately drive our understanding of and ability to predict and manage PPs.


Asunto(s)
Psoriasis , Humanos , Psoriasis/tratamiento farmacológico , Productos Biológicos/uso terapéutico , Erupciones por Medicamentos/etiología
2.
Front Glob Womens Health ; 3: 979708, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36304737

RESUMEN

The onset of cardiovascular disease in women is almost a decade later than men, partly due to the protective effect of estrogen prior to menopause. Recently, it was noted that while there have been advances in improving the morbidity and mortality from CVD in women older than 55 years, the improvement in younger women has been stagnant. The mechanism behind this lag is unclear. This manuscript reviews the literature available on the sex-specific inflammatory response in the context of traditional and non-traditional cardiovascular disease risk factors. Our review suggests that women have a differential inflammatory response to various disease states that increases their risk for CVD and warrants a distinct prioritization from men when calculating cardiovascular disease risk.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...